Search Results

Curebase, a company committed to democratizing access to clinical studies and a leader in decentralized clinical trial execution, is now offering Omnisite™, a flexible site model that leverages a number of the company’s existing capabilities to reach patients where they are at home and in real-world medical settings.

Curebase to Leverage BEKHealth’s Integrated Clinical Research Platform to More Easily Find and recruit Decentralized Trial Participants, Expand into Oncology and New Therapeutic Areas.

Curebase, a company dedicated to democratizing clinical trials through a decentralized model is announcing its partnership with Redenlab, a global leader for speech testing in industry-run clinical trials.

Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics trials that accelerates enrollment and allows sponsors to launch their studies faster.

Curebase, a company committed to democratizing access to clinical studies, has named veteran clinical research executive Sean Lynch as vice president of clinical operations.

Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.

Curebase has raised $40 million in Series B funding to continue development of its end-to-end clinical trial execution model, virtual and hybrid site capabilities, and full eClinical software platform to run modern, patient-centric clinical trials.

Curebase, a company committed to democratizing access to clinical studies, today announced the initiation of the pilot phase of COMPANION, the first clinical investigation of a new digital therapeutic (DTx) for patients with IPF, a rare lung disease.

We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system

Curebase, a company committed to democratizing access to clinical studies, and Portamedic, which provides mobile examination and mobile phlebotomy services in all 50 states and Puerto Rico, have announced an ongoing partnership in which Portamedic will collect blood samples and other tests from participating decentralized clinical trial patients’ homes throughout the U.S.